GSK3B and early-onset autosomal dominant Alzheimer disease: GSK3β inhibition boosts autophagy and promotes toxic protein aggregate clearance, potentially mitigating Alzheimer’s disease and Parkinson’s disease progression (Gu et al., 2019; Wang et al., 2019).